Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Madison A. Nashu"'
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 20, Iss 9, Pp 917-929 (2018)
Current treatment strategies provide minimal results for patients with castration-resistant prostate cancer (CRPC). Attempts to target the androgen receptor have shown promise, but resistance ultimately develops, often due to androgen receptor reacti
Externí odkaz:
https://doaj.org/article/a9ffe03e3d2940b68036e545039e31df
Autor:
Joel Moss, Rebecca L. Nelson, Madison A. Nashu, Nishant Gupta, Francis X. McCormack, Huan Liu, Michael T. Borchers, Benyamin Z. Yaniv, Walter R.F. Donica, Andrew R. Osterburg, Rachel Foot, Kathryn A. Wikenheiser-Brokamp
Publikováno v:
JCI insight. 1(16)
Lymphangioleiomyomatosis (LAM) is a rare lung disease of women that leads to progressive cyst formation and accelerated loss of pulmonary function. Neoplastic smooth muscle cells from an unknown source metastasize to the lung and drive destructive re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f34dd24478c9d6b17f1eec44159bceee
https://pubmed.ncbi.nlm.nih.gov/27734028
https://pubmed.ncbi.nlm.nih.gov/27734028
Hepatocyte growth factor-like protein is required for prostate tumor growth in the TRAMP mouse model
Publikováno v:
Oncotarget
// Juozas Vasiliauskas 1 , Madison A. Nashu 1 , Peterson Pathrose 2 , Sandra L. Starnes 2 and Susan E. Waltz 1,3 1 Departments of Cancer Biology , Cincinnati Veterans Affairs Medical Center, Cincinnati, Ohio 2 Department of Surgery, University of Cin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d59add25870bbe00bec246e61a504e1c
https://pubmed.ncbi.nlm.nih.gov/24980820
https://pubmed.ncbi.nlm.nih.gov/24980820
Autor:
Allie K. Adams, Susanne I. Wells, P K Wagh, L M Privette Vinnedge, Madison A. Nashu, Nicholas A. Pease, Susan E. Waltz, Nancy M. Benight, Jose A. Cancelas, Juana Serrano-Lopez
Publikováno v:
Oncogene
Disease progression and recurrence are major barriers to survival for breast cancer patients. Understanding the etiology of recurrent or metastatic breast cancer and underlying mechanisms is critical for the development of new treatments and improved
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07e280bcf15d2c4437b966618ed60efb
https://pubmed.ncbi.nlm.nih.gov/24954505
https://pubmed.ncbi.nlm.nih.gov/24954505